Peak Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Peak Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2024.
- Peak Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.49M, a 26.5% increase year-over-year.
- Peak Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.23M, a 63.6% increase year-over-year.
- Peak Bio, Inc. annual Operating Income (Loss) for 2023 was -$13.1M, a 10.3% decline from 2022.
- Peak Bio, Inc. annual Operating Income (Loss) for 2022 was -$11.8M, a 30.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)